Alto Neuroscience Inc.

NYSE: ANRO · Real-Time Price · USD
3.15
0.03 (0.96%)
At close: Aug 15, 2025, 3:59 PM
3.14
-0.32%
After-hours: Aug 15, 2025, 05:05 PM EDT

Alto Neuroscience Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a 210K
Cost of Revenue
502K 373K 342K 145K
Gross Profit
-502K -373K -342K 65K
Operating Income
-68.61M -37.81M -29.19M -12.06M
Interest Income
8.85M 2.35M 114K 2K
Pretax Income
-61.43M -36.3M -27.71M -9.19M
Net Income
-61.43M -36.3M -27.71M -9.19M
Selling & General & Admin
21.61M 7.52M 5.16M 3.75M
Research & Development
47M 30.29M 23.69M 8.37M
Other Expenses
-502K n/a n/a n/a
Operating Expenses
68.11M 37.81M 28.85M 12.12M
Interest Expense
-1.38M 1.37M n/a n/a
Selling & Marketing Expenses
n/a n/a -342K -145K
Cost & Expenses
68.61M 37.81M 29.19M 12.27M
Income Tax Expense
n/a n/a n/a n/a
Shares Outstanding (Basic)
24.6M 26.88M 25.57M 25.57M
Shares Outstanding (Diluted)
24.6M 26.88M 25.57M 25.57M
EPS (Basic)
-2.5 -1.35 -1.08 -0.36
EPS (Diluted)
-2.5 -1.35 -1.08 -0.36
EBITDA
-68.61M -34.56M -27.37M -9.04M
EBIT
-62.81M -34.94M -27.71M -9.19M
Depreciation & Amortization
-5.8M 373K 342K 145K